Notch-Mediated Epigenetic Regulation of Voltage-Gated Potassium Currents.
Notch-Mediated Epigenetic Regulation of Voltage-Gated Potassium Currents.
复制标题
DOI:
10.1161/circresaha.116.309877
复制
发表时间:
2016-12-09
影响因子:
20.1
通讯作者:
Rentschler S
中科院分区:
文献类型:
--
作者:
Khandekar A;Springer S;Wang W;Hicks S;Weinheimer C;Diaz-Trelles R;Nerbonne JM;Rentschler S
Ventricular arrhythmias often arise from the Purkinje-myocyte junction and are a leading cause of sudden cardiac death. Notch activation reprograms cardiac myocytes to an “induced Purkinje-like” state characterized by prolonged action potential duration and expression of Purkinje enriched genes. To understand the mechanism by which canonical Notch signaling causes action potential prolongation. We find that endogenous Purkinje cells have reduced peak K+ current, Ito and IK,slow when compared with ventricular myocytes. Consistent with partial reprogramming toward a Purkinje-like phenotype, Notch activation decreases peak outward K+ current density, as well as the outward K+ current components Ito,f and IK,slow. Gene expression studies in Notch-activated ventricles demonstrate upregulation of Purkinje-enriched genes Contactin-2 and Scn5a, as well as downregulation of K+ channel subunit genes that contribute to Ito,f and IK,slow. In contrast, inactivation of Notch signaling results in increased cell size commensurate with increased K+ current amplitudes and mimics physiologic hypertrophy. Notch-induced changes in K+ current density are regulated at least in part via transcriptional changes. Chromatin immunoprecipitation demonstrates dynamic RBP-J binding and loss of active histone marks on K+ channel subunit promoters with Notch activation, and similar transcriptional and epigenetic changes occur in a heart failure model. Interestingly, there is a differential response in Notch target gene expression and cellular electrophysiology in left versus right ventricular cardiac myocytes. In summary, these findings demonstrate a novel mechanism for regulation of voltage-gated potassium currents in the setting of cardiac pathology, and may provide a novel target for arrhythmia drug design.